- Cancer and Blood Diseases (4)
- Cardiology (7)
- Diabetes and Endocrinology (1)
- Fetal Care (2)
- Gastroenterology (3)
- Mental Behavioral Health (2)
- Neonatology (0)
- Nephrology (0)
- Neurology and Neurosurgery (0)
- Orthopaedics (0)
- Pulmonology (0)
- Urology (0)
This is the Header Field in Search Component
This is the rich text under Introduction.
Results (19)
Anesthesia Strategies for Fetoscopic Myelomeningocele (MMC) Repair
Study finds no link between maternal temperature and fetal heart rate during fetoscopic myelomeningocele (MMC) repairs, guiding anesthetic improvements.
Cincinnati Children’s Adds New Cancer and Blood Disease Faculty
The Cancer and Blood Diseases Institute recently welcomed 10 new faculty members, expanding our solid tumor, leukemia, onco-critical care, bone marrow transplantation, immune deficiency, and hematology programs.
Cincinnati Children’s Launches ENGRAFT Network
ENGRAFT, a new learning health network led by Cincinnati Children’s, brings together pediatric and adult centers to improve transplant and cellular therapy outcomes.
Cincinnati Children’s Launches KiteLock™ Trial
Cincinnati Children’s launches a pivotal clinical trial for KiteLock therapy—a breakthrough approach to reducing catheter complications in pediatric intestinal failure patients.
Collaborative Care for Pediatric Liver Patients
Cincinnati Children’s and Akron Children’s mark one year of collaboration to expand access to expert pediatric liver care across Northeast Ohio.
Gene Therapy Research Brings New Hope for Muscular Dystrophy Patients
Our researchers are exploring how gene therapy and cardiac care innovations may improve outcomes for patients with Duchenne muscular dystrophy. Learn about promising new delivery methods and heart-focused strategies.
How Genetics Improve Pre- and Postnatal Care
Explore new insights from Cincinnati Children’s on prenatal genetic testing and diagnosis, presented at the 2025 ISPD meeting.
Hydroxyurea May Help People With HbSC Form of Sickle Cell Disease
A Phase II clinical trial conducted in Ghana suggests that hydroxyurea — already a treatment offered for the most common form of sickle cell disease — also shows benefits for those with the hemoglobin SC (HbSC) variant of the condition.
Interactive Dashboards Improve Diabetes Outcomes
Our health system is transforming pediatric diabetes care with real-time dashboards that close gaps in technology access and improve clinical outcomes.
More Awareness Needed for HCV Screening, Care
FDA-approved therapies now make hepatitis C curable in children—but greater awareness and screening are needed to close critical gaps in care.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026
© 1999-2025 Cincinnati Children's Hospital Medical Center. All rights reserved.
